ProShare Advisors LLC Acquires 2,762 Shares of Humana Inc. $HUM

ProShare Advisors LLC raised its holdings in shares of Humana Inc. (NYSE:HUM) by 13.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,956 shares of the insurance provider’s stock after acquiring an additional 2,762 shares during the quarter. ProShare Advisors LLC’s holdings in Humana were worth $6,136,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Montag A & Associates Inc. grew its stake in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC grew its stake in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 37 shares in the last quarter. Rosenberg Matthew Hamilton grew its stake in shares of Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 68 shares in the last quarter. Larson Financial Group LLC grew its stake in shares of Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after acquiring an additional 81 shares in the last quarter. Finally, Fulcrum Asset Management LLP bought a new position in shares of Humana during the 3rd quarter worth approximately $42,000. 92.38% of the stock is owned by institutional investors.

Insider Transactions at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was acquired at an average price of $185.21 per share, with a total value of $150,020.10. Following the acquisition, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This trade represents a 7.47% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several brokerages have recently weighed in on HUM. Mizuho raised their price target on shares of Humana from $290.00 to $335.00 and gave the stock an “outperform” rating in a research note on Wednesday. Wolfe Research cut shares of Humana from a “strong-buy” rating to a “peer perform” rating in a research note on Wednesday. The Goldman Sachs Group raised their price target on shares of Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. UBS Group raised their price target on shares of Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a research note on Friday. Finally, Evercore increased their price objective on Humana from $195.00 to $250.00 in a report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $263.35.

Humana Trading Up 1.4%

NYSE HUM opened at $307.79 on Friday. The company has a market cap of $36.95 billion, a PE ratio of 32.92, a PEG ratio of 2.82 and a beta of 0.68. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $315.66. The stock has a 50 day moving average of $218.13 and a 200-day moving average of $227.64.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities research analysts anticipate that Humana Inc. will post 9.01 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana’s dividend payout ratio (DPR) is currently 37.86%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.